• image description

    Pharmakure's key focus is Alzheimer's Disease, where no effective
    treatments exist, leading to enormous human and financial cost

    Our strategy is to discover new uses for known compounds
    or drugs through our phenotypic screening methods

    This strategy offers great promise for quickly bringing
    new therapeutic options to Alzheimer's patients

    PharmaKure already owns intellectual property on
    one drug discovered by our screening approach

    This first drug is at the stage of pre-Phase 1
    (first time in humans) assessment

    IF WE COULD DELAY THE AGE OF ONSET OF ALZHEIMER'S DISEASE BY 5 YEARS

    THERE WOULD BE ENORMOUS HUMAN AND FINANCIAL BENEFITS

PharmaKure is a drug discovery company

a spin out from The University of Manchester

© 2013, Pharmakure Limited, All Rights Reserved
Drug Repositioning For Alzheimer's Disease: The Search For a Cure